ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,903Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 717

$999K Total Retail Price of All Prescriptions

Rank: 9 out of 717

363 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 10,977 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

47% of this provider’s prescriptions were for brand-name drugs, compared to an average of 33%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $88 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OMEPRAZOLE 561 518 1 28
AMLODIPINE BESYLATE 485 480 2 2
DIOVAN 483 473 3 13
METOPROLOL SUCCINATE 361 358 4 1
BYSTOLIC 305 287 5 29
LOVAZA 268 261 6 33
NEXIUM 242 195 7 37
CARVEDILOL 237 235 8 6
LOSARTAN POTASSIUM 228 199 9 16
DONEPEZIL HCL 224 224 10 57
ATORVASTATIN CALCIUM 223 215 11 4
CLOPIDOGREL 219 213 12 10
CRESTOR 219 200 12 11
MELOXICAM 215 192 14 82
DIOVAN HCT 209 209 15 26
SIMVASTATIN 190 179 16 3
PLAVIX 183 179 17 12
ADVAIR DISKUS 182 156 18 73
PRAVASTATIN SODIUM 180 162 19 21
METFORMIN HCL 178 171 20 30
ZOLPIDEM TARTRATE 176 155 21 35
PANTOPRAZOLE SODIUM 169 166 22 49
CIPROFLOXACIN HCL 163 144 23 112
GLIMEPIRIDE 145 131 24 59
WARFARIN SODIUM 141 99 25 7
LIDODERM 133 117 26 105
NAMENDA 128 128 27 78
CREON 127 114 28 182
JANUVIA 113 113 29 52
LEVOTHYROXINE SODIUM 111 104 30 23
METFORMIN HCL ER 105 87 31 129
SINGULAIR 103 88 32 95
TAMSULOSIN HCL 99 99 33 70
MICARDIS 97 92 34 92
AMLODIPINE BESYLATE-BENAZEPRIL 88 87 35 54
ENALAPRIL MALEATE 86 67 36 24
NASONEX 83 78 37 207
TRIAMTERENE-HCTZ 82 62 38 60
VOLTAREN 78 73 39 171
PRANDIN 78 72 39 132
RAMIPRIL 77 70 41 15
ISOSORBIDE MONONITRATE ER 76 69 42 20
SPIRIVA 74 52 43 99
FLUTICASONE PROPIONATE 73 63 44 110
CLOTRIMAZOLE-BETAMETHASONE 73 65 44 137
CELEBREX 73 54 44 94
ESCITALOPRAM OXALATE 71 70 47 106
TRAMADOL HCL 70 60 48 61
EXFORGE 70 59 48 66
LIPITOR 66 61 50 19
NAPROXEN 64 59 51 96
IBUPROFEN 61 58 52 168
LISINOPRIL 61 49 52 9
MONTELUKAST SODIUM 59 46 54 168
ATENOLOL 58 45 55 18
VERAPAMIL ER 57 45 56 67
DOXAZOSIN MESYLATE 57 44 56 58
LEXAPRO 56 56 58 243
VENLAFAXINE HCL ER 56 56 58 243
DIVALPROEX SODIUM 55 54 60 103
TORSEMIDE 55 48 60 41
HYDROCHLOROTHIAZIDE 54 45 62 17
MUPIROCIN 52 45 63 184
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 30, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.